Billingham, L. K.; Delay, S. L.; Tripathi, S.; Olson, I. E.; Zilinger, K.; Subbiah, J.; Wang, Z.; Sadagopan, N. S.; Chia, T.-Y.; Najem, H.; Cognet, G.; Katz, J. L.; Vazquez-Cervantes, G. I.; Wang, S.; Wan, H.; Murphy, A. R.; Lipshutz, A. B.; Duffy, J. T.; Valyasnikova, I. V.; Zhang, P.; Heiland, D. H.; Ahmed, A. U.; Lee-Chang, C.; Heimberger, A. B.; Perry, J. S.; Muir, A.; Chandel, N. S.; Miska, J.

Glioblastoma (GBM) is most common and aggressive primary brain tumor in adults, for which standard of care has not changed in twenty years. GBM tumor associated macrophages (TAMCs), consisting of infiltrating myeloid cells from the periphery and resident microglia cells, are pro-tumorigenic, promoting tumor growth. Fructose is one of the most abundant metabolites in the GBM tumor microenvironment (TME), as well as in the healthy central nervous system (CNS). In the CNS and GBM, microglia are the predominant expressors of the fructose transporter GLUT5. Mice lacking the GLUT5 transporter (GLUT5-KO) survive significantly longer after orthotopic implantation of two glioma cell lines than wildtype mice, which is not due to dietary fructose or peripherally derived TAMCs. Investigation of the TME showed that GLUT5-KO mice have more highly activated and inflammatory innate and adaptive immune compartments. Microglia cultured in fructose have a decreased phagocytic ability and exhibit decreased inflammatory capacity due to the polyol pathway promoting redox homeostasis.